APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pressurized Metered Dose Inhaler

A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.

Selected research

Industry Research

Pressurized Metered Dose Inhaler Industry Research Report 2026

27 December 2025123 pages

Choose your research edition.

Industry ResearchPressurized Metered Dose Inhaler Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pressurized Metered Dose Inhaler Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Pressurized Metered Dose Inhaler Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pressurized Metered Dose Inhaler Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pressurized Metered Dose Inhaler Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.

The classification of Pressurized Metered Dose Inhaler includes manual type and smart type. The proportion of manual type in 2019 is about 99%. But the smart metered-dose inhaler will have a much higher growth rate in the future.

Pressurized Metered Dose Inhaler is widely used for Asthma, COPD and Others. The most proportion of Pressurized Metered Dose Inhaler used for Asthma, and the proportion in 2019 is about 48.94%.

Read the full market overview

North America is the largest market, with a market share nearly 44.49% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 26.40%.

Market competition is intense. GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Report Scope

This report quantifies the global Pressurized Metered Dose Inhaler market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pressurized Metered Dose Inhaler Market by Company

GlaxoSmithKline

Chiesi Farmaceutici S.p.A

AstraZeneca

Teva

Merck & Co. Inc

Boehringer Ingelheim

Mylan

Arkon

Pressurized Metered Dose Inhaler Segment by Type

Manual Pressurized Metered Dose Inhaler

Smart Pressurized Metered Dose Inhaler

Pressurized Metered Dose Inhaler Segment by Application

Asthma

COPD

Others

Pressurized Metered Dose Inhaler Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pressurized Metered Dose Inhaler market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pressurized Metered Dose Inhaler and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pressurized Metered Dose Inhaler.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pressurized Metered Dose Inhaler manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pressurized Metered Dose Inhaler by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pressurized Metered Dose Inhaler in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pressurized Metered Dose Inhaler Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Pressurized Metered Dose Inhaler Sales (M Units) of Manufacturers (2021-2026) Table 7. Global Pressurized Metered Dose Inhaler Sales Market Share by Manufacturers (2021-2026) Table 8. Global Pressurized Metered Dose Inhaler Revenue of Manufacturers (2021-2026) Table 9. Global Pressurized Metered Dose Inhaler Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Pressurized Metered Dose Inhaler Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Pressurized Metered Dose Inhaler Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Pressurized Metered Dose Inhaler, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Pressurized Metered Dose Inhaler, Product Type & Application Table 14. Global Pressurized Metered Dose Inhaler Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Pressurized Metered Dose Inhaler by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. GlaxoSmithKline Company Information Table 19. GlaxoSmithKline Business Overview Table 20. GlaxoSmithKline Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. GlaxoSmithKline Pressurized Metered Dose Inhaler Product Portfolio Table 22. GlaxoSmithKline Recent Developments Table 23. Chiesi Farmaceutici S.p.A Company Information Table 24. Chiesi Farmaceutici S.p.A Business Overview Table 25. Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Product Portfolio Table 27. Chiesi Farmaceutici S.p.A Recent Developments Table 28. AstraZeneca Company Information Table 29. AstraZeneca Business Overview Table 30. AstraZeneca Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. AstraZeneca Pressurized Metered Dose Inhaler Product Portfolio Table 32. AstraZeneca Recent Developments Table 33. Teva Company Information Table 34. Teva Business Overview Table 35. Teva Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Teva Pressurized Metered Dose Inhaler Product Portfolio Table 37. Teva Recent Developments Table 38. Merck & Co. Inc Company Information Table 39. Merck & Co. Inc Business Overview Table 40. Merck & Co. Inc Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Merck & Co. Inc Pressurized Metered Dose Inhaler Product Portfolio Table 42. Merck & Co. Inc Recent Developments Table 43. Boehringer Ingelheim Company Information Table 44. Boehringer Ingelheim Business Overview Table 45. Boehringer Ingelheim Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Boehringer Ingelheim Pressurized Metered Dose Inhaler Product Portfolio Table 47. Boehringer Ingelheim Recent Developments Table 48. Mylan Company Information Table 49. Mylan Business Overview Table 50. Mylan Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Mylan Pressurized Metered Dose Inhaler Product Portfolio Table 52. Mylan Recent Developments Table 53. Arkon Company Information Table 54. Arkon Business Overview Table 55. Arkon Pressurized Metered Dose Inhaler Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Arkon Pressurized Metered Dose Inhaler Product Portfolio Table 57. Arkon Recent Developments Table 58. Global Pressurized Metered Dose Inhaler Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 59. Global Pressurized Metered Dose Inhaler Sales by Region (2021-2026) & (M Units) Table 60. Global Pressurized Metered Dose Inhaler Sales Market Share by Region (2021-2026) Table 61. Global Pressurized Metered Dose Inhaler Sales by Region (2027-2032) & (M Units) Table 62. Global Pressurized Metered Dose Inhaler Sales Market Share by Region (2027-2032) Table 63. Global Pressurized Metered Dose Inhaler Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Pressurized Metered Dose Inhaler Revenue Market Share by Region (2021-2026) Table 65. Global Pressurized Metered Dose Inhaler Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Pressurized Metered Dose Inhaler Revenue Market Share by Region (2027-2032) Table 67. North America Pressurized Metered Dose Inhaler Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. North America Pressurized Metered Dose Inhaler Sales by Country (2021-2026) & (M Units) Table 69. North America Pressurized Metered Dose Inhaler Sales by Country (2027-2032) & (M Units) Table 70. North America Pressurized Metered Dose Inhaler Revenue by Country (2021-2026) & (US$ Million) Table 71. North America Pressurized Metered Dose Inhaler Revenue by Country (2027-2032) & (US$ Million) Table 72. Europe Pressurized Metered Dose Inhaler Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Europe Pressurized Metered Dose Inhaler Sales by Country (2021-2026) & (M Units) Table 74. Europe Pressurized Metered Dose Inhaler Sales by Country (2027-2032) & (M Units) Table 75. Europe Pressurized Metered Dose Inhaler Revenue by Country (2021-2026) & (US$ Million) Table 76. Europe Pressurized Metered Dose Inhaler Revenue by Country (2027-2032) & (US$ Million) Table 77. Asia Pacific Pressurized Metered Dose Inhaler Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Asia Pacific Pressurized Metered Dose Inhaler Sales by Country (2021-2026) & (M Units) Table 79. Asia Pacific Pressurized Metered Dose Inhaler Sales by Country (2027-2032) & (M Units) Table 80. Asia Pacific Pressurized Metered Dose Inhaler Revenue by Country (2021-2026) & (US$ Million) Table 81. Asia Pacific Pressurized Metered Dose Inhaler Revenue by Country (2027-2032) & (US$ Million) Table 82. South America Pressurized Metered Dose Inhaler Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. South America Pressurized Metered Dose Inhaler Sales by Country (2021-2026) & (M Units) Table 84. South America Pressurized Metered Dose Inhaler Sales by Country (2027-2032) & (M Units) Table 85. South America Pressurized Metered Dose Inhaler Revenue by Country (2021-2026) & (US$ Million) Table 86. South America Pressurized Metered Dose Inhaler Revenue by Country (2027-2032) & (US$ Million) Table 87. Middle East and Africa Pressurized Metered Dose Inhaler Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Middle East and Africa Pressurized Metered Dose Inhaler Sales by Country (2021-2026) & (M Units) Table 89. Middle East and Africa Pressurized Metered Dose Inhaler Sales by Country (2027-2032) & (M Units) Table 90. Middle East and Africa Pressurized Metered Dose Inhaler Revenue by Country (2021-2026) & (US$ Million) Table 91. Middle East and Africa Pressurized Metered Dose Inhaler Revenue by Country (2027-2032) & (US$ Million) Table 92. Global Pressurized Metered Dose Inhaler Sales by Type (2021-2026) & (M Units) Table 93. Global Pressurized Metered Dose Inhaler Sales by Type (2027-2032) & (M Units) Table 94. Global Pressurized Metered Dose Inhaler Sales Market Share by Type (2021-2026) Table 95. Global Pressurized Metered Dose Inhaler Sales Market Share by Type (2027-2032) Table 96. Global Pressurized Metered Dose Inhaler Revenue by Type (2021-2026) & (US$ Million) Table 97. Global Pressurized Metered Dose Inhaler Revenue by Type (2027-2032) & (US$ Million) Table 98. Global Pressurized Metered Dose Inhaler Revenue Market Share by Type (2021-2026) Table 99. Global Pressurized Metered Dose Inhaler Revenue Market Share by Type (2027-2032) Table 100. Global Pressurized Metered Dose Inhaler Price by Type (2021-2026) & (US$/Unit) Table 101. Global Pressurized Metered Dose Inhaler Price by Type (2027-2032) & (US$/Unit) Table 102. Global Pressurized Metered Dose Inhaler Sales by Application (2021-2026) & (M Units) Table 103. Global Pressurized Metered Dose Inhaler Sales by Application (2027-2032) & (M Units) Table 104. Global Pressurized Metered Dose Inhaler Sales Market Share by Application (2021-2026) Table 105. Global Pressurized Metered Dose Inhaler Sales Market Share by Application (2027-2032) Table 106. Global Pressurized Metered Dose Inhaler Revenue by Application (2021-2026) & (US$ Million) Table 107. Global Pressurized Metered Dose Inhaler Revenue by Application (2027-2032) & (US$ Million) Table 108. Global Pressurized Metered Dose Inhaler Revenue Market Share by Application (2021-2026) Table 109. Global Pressurized Metered Dose Inhaler Revenue Market Share by Application (2027-2032) Table 110. Global Pressurized Metered Dose Inhaler Price by Application (2021-2026) & (US$/Unit) Table 111. Global Pressurized Metered Dose Inhaler Price by Application (2027-2032) & (US$/Unit) Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Pressurized Metered Dose Inhaler Distributors List Table 115. Pressurized Metered Dose Inhaler Customers List Table 116. Pressurized Metered Dose Inhaler Industry Trends Table 117. Pressurized Metered Dose Inhaler Industry Drivers Table 118. Pressurized Metered Dose Inhaler Industry Restraints Table 119. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pressurized Metered Dose Inhaler Product Image Figure 5. Global Pressurized Metered Dose Inhaler Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Pressurized Metered Dose Inhaler Market Size (2021-2032) & (US$ Million) Figure 7. Global Pressurized Metered Dose Inhaler Sales (2021-2032) & (M Units) Figure 8. Global Pressurized Metered Dose Inhaler Average Price (US$/Unit) & (2021-2032) Figure 9. Manual Pressurized Metered Dose Inhaler Product Image Figure 10. Smart Pressurized Metered Dose Inhaler Product Image Figure 11. Asthma Product Image Figure 12. COPD Product Image Figure 13. Others Product Image Figure 14. Global Pressurized Metered Dose Inhaler Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Pressurized Metered Dose Inhaler, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Pressurized Metered Dose Inhaler Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Pressurized Metered Dose Inhaler Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Pressurized Metered Dose Inhaler Sales by Region in 2025 Figure 20. Global Pressurized Metered Dose Inhaler Revenue by Region in 2025 Figure 21. North America Pressurized Metered Dose Inhaler Market Size by Country in 2025 Figure 22. North America Pressurized Metered Dose Inhaler Sales Market Share by Country (2021-2032) Figure 23. North America Pressurized Metered Dose Inhaler Revenue Market Share by Country (2021-2032) Figure 24. United States Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Pressurized Metered Dose Inhaler Market Size by Country in 2025 Figure 28. Europe Pressurized Metered Dose Inhaler Sales Market Share by Country (2021-2032) Figure 29. Europe Pressurized Metered Dose Inhaler Revenue Market Share by Country (2021-2032) Figure 30. Germany Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Pressurized Metered Dose Inhaler Market Size by Country in 2025 Figure 41. Asia Pacific Pressurized Metered Dose Inhaler Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Pressurized Metered Dose Inhaler Revenue Market Share by Country (2021-2032) Figure 43. China Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Pressurized Metered Dose Inhaler Market Size by Country in 2025 Figure 52. South America Pressurized Metered Dose Inhaler Sales Market Share by Country (2021-2032) Figure 53. South America Pressurized Metered Dose Inhaler Revenue Market Share by Country (2021-2032) Figure 54. Brazil Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Pressurized Metered Dose Inhaler Market Size by Country in 2025 Figure 58. Middle East and Africa Pressurized Metered Dose Inhaler Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Pressurized Metered Dose Inhaler Revenue Market Share by Country (2021-2032) Figure 60. Egypt Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Pressurized Metered Dose Inhaler Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Pressurized Metered Dose Inhaler Sales Market Share by Type (2021-2032) Figure 66. Global Pressurized Metered Dose Inhaler Revenue Market Share by Type (2021-2032) Figure 67. Global Pressurized Metered Dose Inhaler Price (US$/Unit) by Type (2021-2032) Figure 68. Global Pressurized Metered Dose Inhaler Sales Market Share by Application (2021-2032) Figure 69. Global Pressurized Metered Dose Inhaler Revenue Market Share by Application (2021-2032) Figure 70. Global Pressurized Metered Dose Inhaler Price (US$/Unit) by Application (2021-2032) Figure 71. Pressurized Metered Dose Inhaler Value Chain Figure 72. Pressurized Metered Dose Inhaler Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Pressurized Metered Dose Inhaler Industry Opportunities and Challenges

Scope & coverage.

Types
  • Manual Pressurized Metered Dose Inhaler
  • Smart Pressurized Metered Dose Inhaler
Applications
  • Asthma
  • COPD
  • Others
Companies covered
  • GlaxoSmithKline
  • Chiesi Farmaceutici S.p.A
  • AstraZeneca
  • Teva
  • Merck & Co. Inc
  • Boehringer Ingelheim
  • Mylan
  • Arkon

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Pressurized Metered Dose Inhaler Market Size (2021-2032)
  4. 2.2.2 Global Pressurized Metered Dose Inhaler Sales (2021-2032)
  5. 2.2.3 Global Pressurized Metered Dose Inhaler Market Average Price (2021-2032)
  6. 2.3 Pressurized Metered Dose Inhaler by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Manual Pressurized Metered Dose Inhaler
  9. 2.3.3 Smart Pressurized Metered Dose Inhaler
  10. 2.4 Pressurized Metered Dose Inhaler by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Asthma
  13. 2.4.3 COPD
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pressurized Metered Dose Inhaler Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Pressurized Metered Dose Inhaler Sales (M Units) of Manufacturers (2021-2026)
  3. 3.3 Global Pressurized Metered Dose Inhaler Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Pressurized Metered Dose Inhaler Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Pressurized Metered Dose Inhaler Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Pressurized Metered Dose Inhaler, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Pressurized Metered Dose Inhaler, Product Type & Application
  8. 3.8 Global Manufacturers of Pressurized Metered Dose Inhaler, Established Date
  9. 3.9 Global Pressurized Metered Dose Inhaler Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 GlaxoSmithKline
  2. 4.1.1 GlaxoSmithKline Company Information
  3. 4.1.2 GlaxoSmithKline Business Overview
  4. 4.1.3 GlaxoSmithKline Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 GlaxoSmithKline Pressurized Metered Dose Inhaler Product Portfolio
  6. 4.1.5 GlaxoSmithKline Recent Developments
  7. 4.2 Chiesi Farmaceutici S.p.A
  8. 4.2.1 Chiesi Farmaceutici S.p.A Company Information
  9. 4.2.2 Chiesi Farmaceutici S.p.A Business Overview
  10. 4.2.3 Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Product Portfolio
  12. 4.2.5 Chiesi Farmaceutici S.p.A Recent Developments
  13. 4.3 AstraZeneca
  14. 4.3.1 AstraZeneca Company Information
  15. 4.3.2 AstraZeneca Business Overview
  16. 4.3.3 AstraZeneca Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 AstraZeneca Pressurized Metered Dose Inhaler Product Portfolio
  18. 4.3.5 AstraZeneca Recent Developments
  19. 4.4 Teva
  20. 4.4.1 Teva Company Information
  21. 4.4.2 Teva Business Overview
  22. 4.4.3 Teva Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Teva Pressurized Metered Dose Inhaler Product Portfolio
  24. 4.4.5 Teva Recent Developments
  25. 4.5 Merck & Co. Inc
  26. 4.5.1 Merck & Co. Inc Company Information
  27. 4.5.2 Merck & Co. Inc Business Overview
  28. 4.5.3 Merck & Co. Inc Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Merck & Co. Inc Pressurized Metered Dose Inhaler Product Portfolio
  30. 4.5.5 Merck & Co. Inc Recent Developments
  31. 4.6 Boehringer Ingelheim
  32. 4.6.1 Boehringer Ingelheim Company Information
  33. 4.6.2 Boehringer Ingelheim Business Overview
  34. 4.6.3 Boehringer Ingelheim Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Boehringer Ingelheim Pressurized Metered Dose Inhaler Product Portfolio
  36. 4.6.5 Boehringer Ingelheim Recent Developments
  37. 4.7 Mylan
  38. 4.7.1 Mylan Company Information
  39. 4.7.2 Mylan Business Overview
  40. 4.7.3 Mylan Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Mylan Pressurized Metered Dose Inhaler Product Portfolio
  42. 4.7.5 Mylan Recent Developments
  43. 4.8 Arkon
  44. 4.8.1 Arkon Company Information
  45. 4.8.2 Arkon Business Overview
  46. 4.8.3 Arkon Pressurized Metered Dose Inhaler Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Arkon Pressurized Metered Dose Inhaler Product Portfolio
  48. 4.8.5 Arkon Recent Developments
5 Global Pressurized Metered Dose Inhaler Market Scenario by Region
  1. 5.1 Global Pressurized Metered Dose Inhaler Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pressurized Metered Dose Inhaler Sales by Region: 2021-2032
  3. 5.2.1 Global Pressurized Metered Dose Inhaler Sales by Region: 2021-2026
  4. 5.2.2 Global Pressurized Metered Dose Inhaler Sales by Region: 2027-2032
  5. 5.3 Global Pressurized Metered Dose Inhaler Revenue by Region: 2021-2032
  6. 5.3.1 Global Pressurized Metered Dose Inhaler Revenue by Region: 2021-2026
  7. 5.3.2 Global Pressurized Metered Dose Inhaler Revenue by Region: 2027-2032
  8. 5.4 North America Pressurized Metered Dose Inhaler Market Facts & Figures by Country
  9. 5.4.1 North America Pressurized Metered Dose Inhaler Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Pressurized Metered Dose Inhaler Sales by Country (2021-2032)
  11. 5.4.3 North America Pressurized Metered Dose Inhaler Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Pressurized Metered Dose Inhaler Market Facts & Figures by Country
  16. 5.5.1 Europe Pressurized Metered Dose Inhaler Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Pressurized Metered Dose Inhaler Sales by Country (2021-2032)
  18. 5.5.3 Europe Pressurized Metered Dose Inhaler Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Pressurized Metered Dose Inhaler Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Pressurized Metered Dose Inhaler Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Pressurized Metered Dose Inhaler Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Pressurized Metered Dose Inhaler Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Pressurized Metered Dose Inhaler Market Facts & Figures by Country
  41. 5.7.1 South America Pressurized Metered Dose Inhaler Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Pressurized Metered Dose Inhaler Sales by Country (2021-2032)
  43. 5.7.3 South America Pressurized Metered Dose Inhaler Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Pressurized Metered Dose Inhaler Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Pressurized Metered Dose Inhaler Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Pressurized Metered Dose Inhaler Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Pressurized Metered Dose Inhaler Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Pressurized Metered Dose Inhaler Sales by Type (2021-2032)
  2. 6.1.1 Global Pressurized Metered Dose Inhaler Sales by Type (2021-2032) & (M Units)
  3. 6.1.2 Global Pressurized Metered Dose Inhaler Sales Market Share by Type (2021-2032)
  4. 6.2 Global Pressurized Metered Dose Inhaler Revenue by Type (2021-2032)
  5. 6.2.1 Global Pressurized Metered Dose Inhaler Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Pressurized Metered Dose Inhaler Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Pressurized Metered Dose Inhaler Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Pressurized Metered Dose Inhaler Sales by Application (2021-2032)
  2. 7.1.1 Global Pressurized Metered Dose Inhaler Sales by Application (2021-2032) & (M Units)
  3. 7.1.2 Global Pressurized Metered Dose Inhaler Sales Market Share by Application (2021-2032)
  4. 7.2 Global Pressurized Metered Dose Inhaler Revenue by Application (2021-2032)
  5. 7.2.1 Global Pressurized Metered Dose Inhaler Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pressurized Metered Dose Inhaler Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Pressurized Metered Dose Inhaler Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Pressurized Metered Dose Inhaler Value Chain Analysis
  2. 8.1.1 Pressurized Metered Dose Inhaler Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Pressurized Metered Dose Inhaler Production Mode & Process
  5. 8.2 Pressurized Metered Dose Inhaler Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Pressurized Metered Dose Inhaler Distributors
  8. 8.2.3 Pressurized Metered Dose Inhaler Customers
9 Global Pressurized Metered Dose Inhaler Analyzing Market Dynamics
  1. 9.1 Pressurized Metered Dose Inhaler Industry Trends
  2. 9.2 Pressurized Metered Dose Inhaler Industry Drivers
  3. 9.3 Pressurized Metered Dose Inhaler Industry Opportunities and Challenges
  4. 9.4 Pressurized Metered Dose Inhaler Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst